Approximately 25% of adults with hypoparathyroidism have a developmental, genetic, autoimmune, metabolic, or environmental condition that impairs either the secretion or action of PTH or alters parathyroid gland mass (Table 1).(1,3,83) Medical hypoparathyroidism is particularly important in pediatric patients. This evidence concerns the gene PTH and hypoparathyroidism.